home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Conclusive Evidence of Gene’s Role in Malaria Drug Resistance

  October, 8 2002 3:04
your information resource in human molecular genetics

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID) have proved conclusively that the malaria-causing parasite "Plasmodium falciparum" became resistant to the anti-malarial drug chloroquine through mutations in a single parasite gene. Chloroquine helped control or eliminate malaria throughout much of the world when it became widely used in the years following World War II. Chloroquine-resistant (CQR) "P. falciparum" emerged in Southeast Asia and South America in the 1950s and spread through much of Africa within two decades. Compared with chloroquine, drugs to treat CQR malaria are more expensive and cause more side effects while working less effectively. The gene finding has potentially important implications for malaria treatment and control.

Message posted by: Rashmi Nemade

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.